Thrombocytopenia: all 703 studies

Page 5 of 8. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.

• Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune ThrombocytopeniaStatus unknownNCT04588194Phase 2
• Neurodevelopmental Outcome After Fetal Neonatal AlloImmune ThrombocytopeniaStatus unknownNCT04529382
• Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Status unknownNCT04518878Phase 1
• Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Status unknownNCT04516837Phase 2
• The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT04481282Phase 2
• TPO-Mimetic Use in Children for Hematopoietic FailureCompletedNCT04478227Early Phase 1
• Avatrombopag for Thrombocytopenia in People With CancerWithdrawnNCT04437953Phase 2
• Umbilical Cord Blood Treatment for Refractory Immune CytopeniaStatus unknownNCT04420494Not applicable
• Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich SyndromeStatus unknownNCT04371939Phase 2
• The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITPStatus unknownNCT04368598Phase 2
• Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.CompletedNCT04350164
• Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary DysplasiaCompletedNCT04348799
• A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT04324060Phase 2/3
• Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune ThrombocytopeniaStatus unknownNCT04320225
• Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell TransplantWithdrawnNCT04312789Phase 2
• Prognostic Value of CD Markers in Immune Thrombocytopenic PurpuraStatus unknownNCT04311593
• Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune ThrombocytopeniaStatus unknownNCT04289207Phase 2
• A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)WithdrawnNCT04274452Phase 3
• Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)CompletedNCT04272970Not applicable
• Thrombo-Elastography Guided Management of ECMOCompletedNCT04268940
• The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT04217148Phase 2
• Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care DevicesCompletedNCT04159064
• Effects of a Platelet Transfusion Best Practices AlertCompletedNCT04155775Not applicable
• Eltrombopag in Chronic ITPStatus unknownNCT04102033Phase 4
• Effect of DNMT SNPs on DNA Methylation in Primary ITPStatus unknownNCT04100876
• A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITPStatus unknownNCT04094805Phase 4
• Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)CompletedNCT04089267Phase 4
• Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic AnemiaCompletedNCT04083014Phase 2
• Diagnostic of Chronic ThrombocytopeniaCompletedNCT04071496
• Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.CompletedNCT04070599Phase 3
• Towards Routine HPA-screening In Pregnancy to Prevent FNAITCompletedNCT04067375
• A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITPWithdrawnNCT04039477Phase 2
• Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune ThrombocytopeniaCompletedNCT04014166Not applicable
• Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and BiomarkerStatus unknownNCT04003220
• Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITPStatus unknownNCT03998982Phase 4
• Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in ReanimationCompletedNCT03979625
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.CompletedNCT03976882Phase 3
• Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)Status unknownNCT03975361Not applicable
• Platelet Transfusion in Sepsis TrialWithdrawnNCT03968484Not applicable
• Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune CytopeniaWithdrawnNCT03965624Phase 2
• The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia PatientsCompletedNCT03951623Phase 1
• A Clinical Trial of Chidamide in the Management of Refractory ITPCompletedNCT03838354Phase 1/2
• Post-Operative Thrombocytopenia After Bio-prosthesis ImplantationCompletedNCT03835598
• Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic PurpuraCompletedNCT03830749Phase 2
• Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With ThrombocytopeniaStatus unknownNCT03823079Phase 2
• Risk Factors for Thrombosis in Immune ThrombocytopeniaCompletedNCT03820960
• Association of Platelet Parameters With Bleeding Severity in Children With ITPCompletedNCT03810352
• Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs ArgatrobanTerminatedNCT03809481Phase 3
• Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)Status unknownNCT03771378Phase 4
• Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant WomenStatus unknownNCT03767803
• A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITPCompletedNCT03754634Phase 2
• Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) HaploinsufficiencyWithdrawnNCT03733067Phase 1/2
• Platelet Reactivity in Septic ShockCompletedNCT03716310
• Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AMLStatus unknownNCT03701217Phase 2/3
• Atorvastatin in Management of Newly Diagnosed ITPStatus unknownNCT03692754Phase 2/3
• Study of Sirolimus in CTD-TP in ChinaStatus unknownNCT03688191Phase 4
• Perioperative Eltrombopag in Patients With Inherited ThrombocytopeniaCompletedNCT03638817Phase 2
• Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal PathwayCompletedNCT03636698
• High-dose Use of rhTPO in CIT PatientsStatus unknownNCT03633019Phase 4
• Mortality Due to Septic Shock Associated With ThrombocytopeniaStatus unknownNCT03617965
• TTP and aHUS in Complicated PregnanciesStatus unknownNCT03605511
• A Study to Evaluate Different Intervals Between Dosing and Feeding on the PharmacokineticsCompletedNCT03603132Phase 1
• Thrombocytopenia Induced by ChemotherapyCompletedNCT03567798Not applicable
• Kinetics of Blood Platelets Transfused to Healthy SubjectsCompletedNCT03561909Not applicable
• Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a ProcedureTerminatedNCT03554759
• Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune ThrombocytopeniaStatus unknownNCT03520049Phase 3
• Romiplostim in Thoracic TransplantationCompletedNCT03515447
• Eltrombopag vs. rhTPO to Increase Platelet Level After HSCTCompletedNCT03515096Phase 3
• Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune ThrombocytopeniaStatus unknownNCT03492515Phase 3
• Autoimmune Cytopenia and BcR InhibitorsStatus unknownNCT03469895
• Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)CompletedNCT03469661
• The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03460808Phase 1/2
• Neonatal Thrombocytopenia Among Newborns Admitted to Neonatal Intensive Care UnitStatus unknownNCT03448952
• Rituximab Combining Bortezomib Versus Rituximab in Management of ITPStatus unknownNCT03443570Phase 3
• French Adult Primary Immune ThrombocytopeniaStatus unknownNCT03429660
• Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICTCompletedNCT03421392
• Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive TherapyTerminatedNCT03391856Phase 2/3
• The Association Between Platelet Reactivity and Bleeding Risk in Adult ITPStatus unknownNCT03377439
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.WithdrawnNCT03343847Phase 3
• Evaluation of HRQoL in Adult With Immune Thrombocytopenia in ChinaStatus unknownNCT03324087
• The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03304288Phase 2
• Management and Outcomes of Anti-thrombotic Medication Use in ThrombocytopeniaStatus unknownNCT03288441
• A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)CompletedNCT03275454Phase 1
• Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced ThrombocytopeniaStatus unknownNCT03269019
• The Study of Different Dose Rituximab in the Treatment of ITPCompletedNCT03258866Phase 4
• Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITPStatus unknownNCT03252457Phase 3
• Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains MalaysiaCompletedNCT03251547
• Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell TransplantationCompletedNCT03236220Phase 2
• Reposition of Second Line Treatment in Chronic Immune ThrombocytopeniaCompletedNCT03229746Phase 4
• The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune ThrombocytopeniaActive, not recruitingNCT03201848Phase 4
• Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic PurpraStatus unknownNCT03183284
• H. Pylori Eradication for Moderate ITPStatus unknownNCT03177629Phase 3
• Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic PurpuraStatus unknownNCT03172676Phase 4
• The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related ThrombocytopeniaStatus unknownNCT03169348Not applicable
• A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)CompletedNCT03164915Phase 3
• Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & MycophenolateCompletedNCT03156452Phase 3
• Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune ThrombocytopeniaCompletedNCT03154385Not applicable
• Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)Status unknownNCT03147638Phase 3
• Monitoring Outcome in Neonatal ThrombocytopeniaCompletedNCT03110887
• A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITPCompletedNCT03102593Phase 2

← Thrombocytopenia overview